The present invention is directed to methods of inhibiting a tauopathy in a patient by administration of a compound of formula I:
Novel aminothienopyridazine compounds are also described.
本发明涉及通过给予I型化合物来抑制患者的tau病变的方法:还描述了新的氨基噻吩吡嗪化合物。
[EN] AMINOTHIENOPYRIDAZINE INHIBITORS OF TAU ASSEMBLY<br/>[FR] INHIBITEURS AMINOTHIÉNOPYRIDAZINIQUES DE L'ASSEMBLAGE DES MICROTUBULES SOUS L'EFFET DE LA PROTÉINE TAU
申请人:UNIV PENNSYLVANIA
公开号:WO2011037985A8
公开(公告)日:2011-06-09
Hussein; Atalla; Kamal El-Dean, Pharmazie, 1995, vol. 50, # 12, p. 788 - 791
作者:Hussein、Atalla、Kamal El-Dean
DOI:——
日期:——
Hussein, A. M.; Atalla, A. A.; El-Dean, A. M. Kamal, Polish Journal of Chemistry, 1995, vol. 69, # 12, p. 1642 - 1648
作者:Hussein, A. M.、Atalla, A. A.、El-Dean, A. M. Kamal